SCHEMBL6168319

SCHEMBL6168319

COc1ccc(COc2ccc(Cl)cc2C(=O)CCC(C)=O)cc1.COc1ccc(COc2ccc(Cl)cc2C=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 3/20 0.42
MRGPRX4 Q96LA9 3/20 0.42
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
KDM4E B2RXH2 2/20 0.40
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
HDAC8 Q9BY41 2/20 0.40
MAOA P21397 2/20 0.40
MAOB P27338 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
TUBB1 Q9H4B7 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5627949 0.92 MRGPRX4 (0.48) CCR5MRGPRX4MTNR1AMTNR1BALDH1A1
SCHEMBL5631282 0.85 TUBB1 (0.51) CCR5MRGPRX4ALDH1A1KDM4EMAPT
SCHEMBL5629610 0.84 MAOA (0.53) MRGPRX4MTNR1AMTNR1BALDH1A1KDM4E
SCHEMBL6166950 0.81 ERN1 (0.52) CCR5MRGPRX4ALDH1A1KDM4EMAPT
SCHEMBL5474984 0.80 CCR5 (0.53) CCR5MRGPRX4MAOAMAOB
SCHEMBL5465872 0.79 PTGER1 (0.57) CCR5MRGPRX4KMT2A
SCHEMBL5629550 0.79 LRRK2 (0.55) CCR5MTNR1AMTNR1BPOLBHDAC8
SCHEMBL17770539 0.77 MRGPRX4 (0.67) CCR5MRGPRX4KDM4EMAPTKMT2A
SCHEMBL5627428 0.76 MAOB (0.47) MRGPRX4MTNR1AMTNR1BMAOB
SCHEMBL5629957 0.76 MTNR1A (0.45) MTNR1AMTNR1BKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509499-A1 PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES GLAXO GROUP LIMITED (GB) 2005-03-02 EP disclosed
WO-2003101959-A1 PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES GLAXO GROUP LIMITED (GB) 2003-12-11 WO disclosed